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Aims To study recovery of segmental wall thickening (SWT), ejection fraction (EF),
and end-systolic volume (ESV) after acute myocardial infarction (AMI) in patients
who underwent primary stenting with drug-eluting stents. Additionally, to evaluate
the predictive value of magnetic resonance imaging (MRI)-based myocardial perfusion
and delayed enhancement (DE) imaging.
Methods and results Twenty-two patients underwent cine-MRI, first-pass perfusion,
and DE imaging 5 days after successful placement of a drug-eluting stent in the
infarct-related coronary artery. Regional myocardial perfusion and the transmural
extent of DE were evaluated. A per patient perfusion score was calculated and
consisted of a summation of all segmental scores. Myocardial infarct size was quanti-
fied by measuring the volume of DE. At 5 months after AMI, cine-MRI was performed
and SWT, EF, and ESV were quantified. EF increased from 48+ 11 to 55+ 9%
(P, 0.01). SWT at 5 months was inversely related to baseline segmental DE scores
(P, 0.001) and segmental perfusion scores (P, 0.001). EF and ESV at 5 months
were related to acute infarct size (R2 ¼ 0.65; P, 0.001 and R2 ¼ 0.78; P, 0.001,
respectively) and the calculated perfusion score (R2 ¼ 0.23; P ¼ 0.02 and R2 ¼ 0.14;
P ¼ 0.09, respectively) at baseline.
Conclusion Marked recovery of left ventricular function was observed in patients
receiving a drug-eluting stent for AMI. DE imaging appears to be a better prognosti-
cator than perfusion imaging.
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Introduction
At present, the preferred reperfusion treatment for
patients with acute myocardial infarction (AMI) is early
primary angioplasty with the placement of a drug-eluting
stent in the infarct-related coronary artery.1–3 Early res-
toration of coronary blood flow by primary angioplasty
salvages myocardium at risk and reduces infarct size,
but may also lead to distal embolization and microvascu-
lar plugging, resulting in microvascular obstruction.4,5
These regions with microvascular obstruction within the
infarcted myocardium can be detected by first-pass
perfusion imaging performed with magnetic resonance
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imaging (MRI).6 Total myocardial infarct size (region with
myocyte necrosis) and the transmural extent of infarc-
tion can be demonstrated with delayed enhancement
(DE) imaging performed 10–20 min following perfusion
imaging.7 Although previous studies demonstrated the
value of perfusion and DE imaging for predicting regional
and global myocardial function at long-term follow-up
after AMI,8–13 the results of these studies have been
equivocal. Differences in outcome may have been
caused by differences in reperfusion therapy, time to
reperfusion, and timing of baseline scan. In the present
study, a well-defined group of patients who suffered
AMI underwent myocardial perfusion and DE imaging 5
days after primary stenting with a drug-eluting stent.
Specifically, we studied segmental wall thickening
(SWT), ejection fraction (EF), end-systolic (ESV) and
end-diastolic volume (EDV) at 5 months after AMI.
Additionally, we investigated the predictive values of
perfusion and DE imaging.
Methods
Patient population
Patients with an AMI who received a drug-eluting stent in the
infarct-related coronary artery within 6 h of onset of symptoms
were possible candidates for the present study. Inclusion of
patients was hampered by the fact that patients referred from
other hospitals were transferred back within a few hours after
primary angioplasty. Eventually, we studied 30 patients (25 male,
53+ 10 years old) admitted to the coronary care unit with AMI.
Three possible candidates refused to participate: one patient
was visiting from another country, two patients were claustropho-
bic. Diagnosis of AMI was based on clinical symptoms, ST-segment
elevation on electrocardiogram, and angiographically demon-
strated occlusion of a coronary artery. All culprit lesions were
stented with a drug-eluting stent within 6 h (mean 2.5 h) of
onset of symptoms. Thrombolysis in myocardial infarction (TIMI)
flow grade 3 was obtained in all vessels. Exclusion criteria con-
sisted of any contraindication to MRI. All participants gave
informed consent to the study protocol, which was approved by
the medical ethics committee of the Erasmus MC, Rotterdam.
Of the original study population, 22 patients had the first MRI
scan 5+ 3 days after admission and the second MRI scan 20+ 7
weeks later. Eight patients did not undergo a second scan: one
patient died of a stroke (non-cardiac death), two patients had a
defibrillator implanted, and five patients refused to come back.
MRI protocol
A clinical 1.5 T MRI scanner with a dedicated cardiac four-
element phased-array receiver coil was used for imaging (Signa
CV/i, GE Medical systems, Milwaukee, WI, USA). Repeated
breath-holds and gating to the electrocardiogram were applied
to minimize the influence of cardiac and respiratory motion on
data collection. The first ce-MRI protocol consisted of cine-
MRI, first-pass perfusion imaging, and DE imaging. The second
MRI protocol consisted of cine-MRI alone.
SWT and left ventricular volumes were assessed with cine-MRI
using a steady-state free-precession technique (FIESTA) with the
following imaging parameters: 6–10 s per breath-hold per slice
(depending on heart rate); 24 phases per slice location; field of
view (FOV), 36  36 cm2; TR, 3.4; TE, 1.4; flip angle, 458;
matrix, 160 128; bandwidth, 83 kHz; 0.75 NEX. To cover the
entire left ventricle, 9–12 consecutive slices of 8 mm were
planned in short axis view (gap of 2 mm) perpendicular to
the horizontal long axis (four-chamber view) of the left ventricle.
First-pass perfusion imaging was performed during 30–40
consecutive heart beats after administration of gadolinium-
DTPA (0.1 mmol/kg, Magnevistw, Schering, Berlin, Germany).
The pulse sequence consisted of a preparation sequence fol-
lowed by an interleaved gradient-echo echo-planar sequence.14
The temporal resolution per slice was 120 ms and allowed
imaging of five to eight slices within each R–R interval, depend-
ing on the heart rate. The following imaging parameters were
used: FOV, 36  36 cm2; rectFOV, 0.75; TR, 6.8; TE, 1.2; ET, 4;
bandwidth, 125 kHz; flip angle, 208; matrix, 128  96.
Perfusion images were planned to cover the basal, mid, and
apical parts of the left ventricle in the same direction as the
cine images.
Myocardial distribution of DE was studied 10–20 min following
perfusion imaging with a 2D T1-weighted inversion recovery
gradient-echo sequence with the following imaging parameters:
FOV, 40  32 cm2; slice thickness, 8 mm; gap 2 mm; TR, 7.3;
TE, 1.6; flip angle, 208; TI, 180–275 ms; matrix, 256  192; 1
NEX; bandwidth, 17.9 kHz. The inversion time was adjusted
per patient to null the signal of remote myocardium. Slice
locations of the DE images were copied from the cine images.
Data analysis and definitions
First-pass perfusion, DE, and cine-MRI images were matched for
position using anatomical landmarks like papillary muscles and
the insertion of the right ventricle. For regional analysis, the
left ventricle was divided into 16 myocardial segments. Two
investigators (T.B. and R.J.v.G.), blinded to the clinical data,
analysed all perfusion and DE segments and a decision was
made on the basis of consensus.
Dedicated post-processing software was used to quantify left
ventricular wall thicknesses and left ventricular volume (centre-
line method; Mass, Medis, Leiden, The Netherlands). SWT was
calculated by subtracting the end-diastolic wall thickness from
the end-systolic wall thickness and was expressed in millimetres.
ESV and EDV were quantified by drawing endocardial and epi-
cardial contours on the short axis series of the cine-MRI images
and EF was calculated as: (EDV2 ESV)/EDV  100%. Papillary
muscles were considered to be part of the left ventricular
lumen and hence included in the left ventricular volume.
Myocardial perfusion was evaluated per segment and scored
as: 1, normal perfusion (homogeneous enhancement of myo-
cardium); 2, mild perfusion defect (subendocardial layer of
hypoenhancement); and 3, severe perfusion defect (.30% trans-
mural extent of hypoenhancement) (Figure 1 ). A myocardial
perfusion score was calculated per patient and consisted of a
summation of all segmental perfusion scores. All patients had
the same amount of segments (16) in the calculated perfusion
score. DE-myocardium was clearly differentiated from remote
myocardium (nulled signal) with the use of an inversion recovery
pulse sequence. The volume of DE was quantified by manually
selecting the enhanced regions from the consecutive 2D slices
encompassing the left ventricle. DE volume was multiplied by
1.05 g/mL to obtain myocardial infarct mass (1 mL corresponds
to 1.05 g). Also, the transmural extent of DE was scored per
segment as: 1 ¼ 0% (no DE), 2 ¼ 1–25% (transmural extent of
DE), 3 ¼ 26–50%, 4 ¼ 51–75%, and 5 ¼ 76–100%. A myocardial
segment was judged as non-assessable if the region of DE could
not be differentiated clearly from the healthy myocardium
(breathing artifacts and erroneous ECG triggering).
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Statistical analysis
Continuous data are expressed as mean + standard deviation,
and dichotomous data are expressed as numbers and per-
centages. Paired Student’s t-tests were applied to evaluate
differences in EF, ESV, and EDV between baseline (i.e. 5 days
post-AMI) and follow-up (i.e. 5 months post-AMI). The relation-
ship between the baseline DE scores and follow-up SWTwas ana-
lysed by one-way analysis-of-variance (ANOVA). However, these
analyses should be interpreted with care as possible correlations
between segments within patients might exist with consequent
possible underestimates for the standard errors and hence for
the corresponding P-values. Univariate linear regression analyses
were applied to evaluate the relationship between the separate
prediction variables (CPK, the per patient calculated perfusion
score, acute infarct mass) and EF, ESV, and EDV at follow-up.
Similar analyses were performed to study the relationship
between the separate prediction variables and the change in
EF, ESV, and EDV between baseline and follow-up. Multiple
linear regression analyses were then applied to evaluate to
what extent the separate prediction variables had additive pre-
dictive value for EF, ESV, and EDV at follow-up. The first model
evaluated the additive predictive value of the calculated per-
fusion score in addition to CPK. The second model evaluated
the additive predictive value of acute infarct mass in addition
to CPK. The third model evaluated the additive predictive
value of the calculated perfusion score and the acute infarct
mass in addition to CPK. All prediction variables were put in
the model at once (no elimination procedure). The linearity
assumption was assessed by examining the scatter plots
(Figures 3 and 5 ) and these demonstrated that no other than
linear relationships were to be expected. Furthermore, a
normal distribution of the residuals was found (P–P plots of
regression standardized residuals) and the mean value of the
residuals was zero. We report regression coefficients (b) with
95% confidence intervals, P-values, and model R2-values (per-
centage of variance in the outcome variable explained by the
prediction variable). All tests were two-sided, and statistical sig-
nificance was accepted at P  0.05. SPSS for Windows, release
11.0.1, SPSS Inc., was used for all analyses.
Results
Patient population
Fifteen patients had an anterior AMI, whereas seven
patients had an AMI of the inferior or lateral wall. Mean
peak CPK level in all patients was 3112+ 2001 U/L (range
187–7359 U/L). More patient characteristics are listed in
Table 1. EF increased from 48+ 11% at baseline to
55+ 9% (P, 0.01) at follow-up. ESV remained unchanged
(84+ 4 to 81+ 4 mL; P ¼ 0.6), but EDV increased from
160+ 44 to 172+ 55 mL at follow-up (P ¼ 0.03).
Regional analysis
Myocardial perfusion could be evaluated in all 352
segments. In 30 (9%) segments, a mild subendocardial
perfusion defect was detected and 30 (9%) segments
exhibited a severe perfusion defect extending beyond
the subendocardium (Figure 1, Table 2 ). All perfusion
defects were located within the perfusion territory of
the infarct-related coronary artery. An inverse relationship
Figure 1 First-pass perfusion images in patients 5 days after AMI indica-
ting (A ) subendocardial perfusion defect (score 2) in the inferior wall and
(B ) a severe perfusion defect in the interventricular septum extending
beyond the subendocardium (score 3).
Table 1 Patient characteristics (n ¼ 22)
Age (years) 52+ 12
Men 16 (73)
Smoking 15 (68)
Diabetes mellitus 1 (5)
Hypertension 6 (27)
Hypercholesterolaemia 5 (23)
Family history of coronary artery disease 12 (55)
Post-AMI
Left ventricular EF (%) 48+ 11
Creatine kinase peak (IU) 3112+ 2001
Anterior infarction 15 (68)
Inferior/lateral infarction 7 (27)
Abciximab 14 (64)
ACE inhibitor 18 (82)
b-Blocker 22 (100)
Clopidogrel 22 (100)
Statin 20 (91)
Aspirin 22 (100)
Values are presented as number (%) or mean+ standard deviation.
1072 T. Baks et al.
was found for the perfusion status of the microvascula-
ture at 5 days after AMI and SWT at 5 months after AMI
(P, 0.001, Figure 2 ). The transmural extent of DE
could be evaluated in 320 segments. Thirty-two segments
(9%) were not assessable due to impaired image quality.
In 105 (32%) segments, a pattern of DE was detected
within the perfusion territory of the infarct-related
coronary artery (Table 2 ). An inverse relationship was
found for the transmural extent of DE at 5 days after
AMI and SWTat 5 months after AMI (P, 0.001, Figure 3 ).
Global left ventricular analysis
A positive correlation between time to reperfusion and
the perfusion score (R ¼ 0.48, P, 0.05) was observed.
Univariate regression analysis revealed that the per
patient calculated perfusion score was statistically
significantly related to EF at follow-up, such that patients
with the lowest perfusion score had the highest EF
(R2 ¼ 0.23; Figure 4, Table 3 ). Baseline calculated
perfusion scores were not related to ESV and EDV at
follow-up. In addition, no relationship was found for
the calculated perfusion score and the change in EF,
ESV, and EDV between baseline and follow-up.
Univariate regression analysis revealed that quantified
acute infarct mass was statistically significantly related
to EF (R2 ¼ 0.65), ESV (R2 ¼ 0.78), and EDV (R2 ¼ 0.68)
at 5 months post-AMI (Figure 5, Table 3 ). Acute infarct
mass was also associated with the change in ESV
(R2 ¼ 0.37) and EDV (R2 ¼ 0.44), but not with the
change in EF (R2 ¼ 0.19). Quantified acute myocardial
infarct mass was correlated with peak CK concentrations
(R ¼ 0.76, P, 0.001). Univariate regression analysis
revealed that CPK peak concentrations were statistically
significantly related to EF (R2 ¼ 0.33), ESV (R2 ¼ 0.28),
and EDV (R2 ¼ 0.22) at follow-up. The results of
the multiple regression analyses are listed in Table 3.
The calculated perfusion score had no additive predictive
value in addition to CPK with regard to EF, ESV, and EDV
at follow-up. Acute infarct mass had additive predictive
value in addition to CPK with regard to EF, ESV, and EDV
at follow-up. Finally, with all prediction variables in the
model, acute infarct mass was the only significant predic-
tor of EF, ESV, and EDV at 5 months after infarction.
Discussion
The present study demonstrates the recovery of left
ventricular function in patients who suffered AMI and
were treated with a drug-eluting stent in the infarct-
related coronary artery within 6 h of onset of symptoms.
Additionally, the predictive value of perfusion and DE
imaging performed at 5 days after AMI was evaluated.
The main findings were that (i) a marked increase in
overall mean EF was observed compared with previously
published data,9,11 (ii) EF, ESV, and EDV at 5 months
after AMI can be estimated by performing ce-MRI 5 days
Figure 2 Myocardial segments with mild or severe perfusion defects
demonstrated impaired SWT at 5 months post-AMI (ANOVA, P , 0.001).
1, normal perfusion; 2, subendocardial perfusion defect; 3, severe
perfusion defect (also Figure 1).
Figure 3 SWTat 5 months post-AMI is inversely related to the transmural
extent of DE at 5 days post-AMI (ANOVA, P, 0.001).
Table 2 An overview of all segmental perfusion and DE scores
Segmental
perfusion score
Segmental DE score Total number of
segments
1 2 3 4 5
1 212 18 11 11 8 260
2 3 3 14 5 5 30
3 0 0 4 6 20 30
Total number of
segments
215 21 29 22 33 320
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after AMI. DE imaging appears to be a better prognostica-
tor than perfusion imaging, and (iii) although epicardial
coronary blood flow was restored in all patients within
6 h of onset of symptoms, microvascular obstruction
was identified with perfusion imaging at 5 days post-AMI
in 19 patients (87%).
Previous studies have investigated the recovery of
regional and global left ventricular function in patients
who suffered AMI by performing ce-MRI. However,
results of these studies have been equivocal. Gerber
et al.10 performed perfusion and DE imaging 4 days
after AMI and found that perfusion imaging was less
accurate than DE imaging in predicting regional contrac-
tile recovery at 7 months. In contrast, Taylor et al.13
performed perfusion imaging in patients within 24 h
after AMI and reported that a delayed wash-in of contrast
in the infarcted myocardium was a better predictor than
DE imaging of recovery of SWTand EF 3 months after AMI.
In the present study, EF, ESV, and EDV at 5 months after
AMI appeared to be better predicted by DE imaging
than by perfusion imaging. Furthermore, an inverse
relationship between DE and regional contractile func-
tion after 5 months of follow-up was observed with
minimal SWT in segments with .75% transmural extent
of DE. The majority of the studies using only DE
imaging reported an inverse relationship between the
transmural extent of DE and the improvement in regional
contractile function, with generally minimal improve-
ment in dysfunctional segments with a .75% transmural
extent of DE. For example, Ingkanisorn et al.11 assessed
SWT in patients after AMI and reported an inverse
relationship between the transmural extent of DE and
SWT at follow-up study. Choi et al.,8 reported that only
5% of segments with a .75% transmural extent of DE
demonstrated an improved contractile function at
follow-up, whereas Beek et al.9 reported improvement
in 29% of these segments, although severe dysfunction
remained present in the majority of these segments. In
contrast to all other studies, Petersen et al.12 reported
that only segments with a .75% transmural extent of
DE improved.
The different outcomes in the various studies are diffi-
cult to explain, but could be caused by a number of
confounding factors. First, patients with different reper-
fusion strategies for AMI, such as primary angioplasty,
thrombolysis, and spontaneous resolution of infarct
symptoms, were included. Primary PCI with the place-
ment of a drug-eluting stent in the infarct-related
artery is presently the preferred reperfusion treatment
for AMI. TIMI 3 flow in the infarct-related artery can be
accomplished in most cases and very low numbers of
restenosis have been reported. Residual stenosis or re-
stenosis of an infarct-related artery is often found in
patients treated with thrombolysis and this influences
the remodelling process. Secondly, time to reperfusion
varied from,6 h13 to 1 month11 after onset of symptoms.
Time to reperfusion determines the amount of stunned
(salvaged) and necrotic myocardium15 and the integrity
of the microvasculature.4,5 Thirdly, baseline scans were
performed between ,24 h13 up to 21 days after AMI.12
Myocardial infarct evolution is a complex process of
early infarct expansion (up to 48 h post-AMI)16 followed
by myocardial infarct shrinkage in time.11 Perfusion and
DE imaging parameters will subsequently alter with
proceeding time after AMI. Infarct size might be under-
estimated with DE imaging if performed too early after
AMI. We performed baseline scans in a clinically appli-
cable time interval between completing stabilization on
Figure 4 The calculated perfusion score per patient correlated better with EF at 5 months after AMI than the change in EF between 5 days and 5 months
post-AMI. The calculated perfusion score was not related to ESV and EDV at 5 months follow-up and the change in ESV and EDV between 5 days and
5 months post-AMI (D ¼ change between 5 days and 5 months).
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the coronary care unit and discharge home from the
cardiology ward. Fourthly, the chosen endpoints per
study varied from the change in regional contractile
function and EF to contractile function and EF at
follow-up. In the present study, a marked increase in
overall mean EF was observed from 48+ 11% at baseline
to 55+ 9% at follow-up. However, a moderate corre-
lation was found between DE and perfusion imaging and
the change in EF, ESV, and EDV between 5 days and
5 months post-AMI. Improvement of myocardial con-
tractile function is dependent on recovery of stunned
myocardium and compensatory hypertrophy of salvaged
myocardium during left ventricular remodelling. It
is still unknown in what time span recovery of contrac-
tile function of dysfunctional stunned myocardium can
be expected and the degree of compensatory hyper-
trophy is influenced by numerous factors, such as: neuro-
humoral stimulation, medication, etc. Although a marked
increase in EF was observed in the present study, it is
possible that with baseline scans performed earlier
after AMI we might have observed an even greater
improvement in EF. Predicting the change in EF, ESV,
and EDV during this complex process of left ventricular
remodelling might lead to false interpretations of recov-
ery as baseline values may fluctuate during the first
period after AMI. For this reason, we correlated perfusion
and DE imaging with EF, ESV, and EDV at 5 months after
AMI. EF, ESV, and EDV were chosen as endpoints as
several studies showed that these endpoints are major
determinants of clinical outcome after AMI.17
Although the number of patients in the present study is
relatively small, DE imaging appears to be a better prog-
nosticator than perfusion imaging. DE imaging might be a
better predictor of EF, ESV, and EDV at 5 months after AMI
as total infarct size remains underestimated with per-
fusion imaging. Myocardial perfusion defects, as ident-
ified with perfusion imaging, correspond to the region
of microvascular obstruction within the infarcted
region, but do not include necrotic myocardium with an
intact microvasculature and hence normal perfusion16
(Table 2 ). In contrast, with DE imaging entire myocardial
infarct size, including the region with microvascular
obstruction, is assessed. In a canine model of AMI, total
infarct size (DE imaging) and the extent of microvascular
obstruction (perfusion imaging) corresponded to post-
mortem histology findings.16 DE imaging allows the visu-
alization of infarcted myocardium, as a contrast agent
like gadolinium-DTPA enhances the signal in regions
with myocyte necrosis. X-ray microanalysis showed an
accumulation of gadolinium-DTPA exclusively in the
infarcted myocardium 10–20 min after intravenous
administration.18 The results of this study show that an
imaging technique which allows the differentiation
between viable and non-viable myocytes might be
preferred over an imaging technique that solely visual-
izes the integrity of the microvasculature. Contrast echo-
cardiography, besides having the great advantage of
being a bedside imaging tool, only allows the assessment
of microvasculature integrity and does not provide
accurate information regarding infarct size. Another
currently available non-invasive imaging modality is
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nuclear medicine, which allows the differentiation
between regions with viable and non-viable myocytes
but is hampered by the currently offered low spatial reso-
lution. ce-MRI allows the assessment of total infarct size
and provides detailed information on regional and global
left ventricular function. Unfortunately, its availability is
still limited.
Methodological considerations
The size of the present study population is relatively small
and conclusions for subgroups, such as patients with
diabetes, women vs. men, etc., cannot be drawn.
Furthermore, a possible selection bias could have been
present in this study as eight patients were unable
or refused to undergo a second MRI. Importantly, none of
these patients dropped out due to cardiac death or
severe heart failure, making selection bias unlikely. In
the present study, we did not perform angiographic
follow-up to exclude in-stent restenosis, but all patients
received a drug-eluting stent in the infarct-related
coronary artery with very low numbers of restenosis
reported.3 There was no clinical evidence of recurrent
myocardial ischaemia. Quantification of the volume of
microvascular obstruction is hampered by the low spatial
resolution offered by the currently available acquisition
technique and the temporal resolution, which does not
allow coverage of the whole ventricle in one R–R interval.
Conclusions
In the era of primary stenting with drug-eluting stents as
reperfusion treatment for patients with AMI, marked
recovery of left ventricular function is observed. Global
left ventricular function at 5 months post-AMI can be
estimated by performing ce-MRI at 5 days post-AMI. DE
imaging appears to be a better prognosticator than per-
fusion imaging.
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